FDA Asked, Sarepta Refused To Stop Elevidys Shipments After Third Death With Gene Therapy Vector
DMD Product Under Agency Investigation Since June 24
The FDA began investigating Elevidys in June after a second DMD patient died from acute liver failure (Shutterstock) 
